Patient advocate Cindy Chmielewski, also known as the "Myeloma Teacher," has been living with multiple myeloma for nearly 15 years. After experiencing excruciating back pain for two years, she was diagnosed with IgG Kappa stage 3 multiple myeloma. After learning more about her diagnosis, she now helps other myeloma patients learn more about the disease and the importance of being actively involved in your care.

In this conversation, she speaks with Dr. Caitlin Costello a hematologistoncologist at the University of California, San Diego and Dr. Sagar Lonial, the chief medical officer at the Winship Cancer Institute at Emory University.

They discuss cuttingedge treatments and therapies for both transplanteligible and transplantineligible patients, combination therapies and the necessity of stem cell transplants.

Full story & transcript → https://www.thepatientstory.com/medic...

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story

Contents of this Video:
00:00 Intro
04:10 Transplant eligible and transplant ineligible patients
06:51 Improving frailty in patients
07:53 Treatment for transplant ineligible patients
10:33 What is maintenance therapy?
12:30 Updates on the MAIA trial
15:02 Using 3 vs 4 drugs for treating transplant eligible
17:23 Do you think the 4drug combination will be the new standard of care?
18:47 Who is eligible for quadbased therapy?
20:26 What does it mean to be high risk?
21:39 Side effects for different drug combinations
25:03 Necessity of stem cell transplant for patients
30:50 IVIG and daratumumab
32:28 Lowering dexamethasone for frail population
37:10 FasT CART cells
39:11 Seeing a myeloma specialist

#multiplemyeloma #multiplemyelomaawareness #MMSM #thepatientstory #cancersurvivor #cancerstories #ASH22 #myelomatreatment #bloodcancer #cancer